1 Min Read
Aug 30 (Reuters) - Medicines Co
* The Medicines Company announces FDA approval of Vabomere (meropenem and vaborbactam)
* Vabomere expected to be available in Q4 of 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.